Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

This study has been completed.
Sponsor:
Information provided by:
Galderma Brasil Ltda.
ClinicalTrials.gov Identifier:
NCT01063218
First received: February 4, 2010
Last updated: March 9, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)